Cargando…
EVEREST study report 2: imaging and grading protocol, and baseline characteristics of a randomised controlled trial of polypoidal choroidal vasculopathy
PURPOSE: To describe the imaging standards, grading protocol and baseline characteristics of polypoidal choroidal vasculopathy (PCV) from the EVEREST study. METHODS: In a prospective, multicentre study, confocal scanning laser ophthalmoscope indocyanine green angiography (ICGA) was performed using a...
Autores principales: | Tan, Colin S, Ngo, Wei Kiong, Chen, Jian Ping, Tan, Nikolle W, Lim, Tock Han |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4413842/ https://www.ncbi.nlm.nih.gov/pubmed/25758601 http://dx.doi.org/10.1136/bjophthalmol-2014-305674 |
Ejemplares similares
-
EVEREST study report 3: diagnostic challenges of polypoidal choroidal vasculopathy. Lessons learnt from screening failures in the EVEREST study
por: Tan, Colin S., et al.
Publicado: (2016) -
EVEREST study report 4: Fluorescein angiography features predictive of polypoidal choroidal vasculopathy
por: Tan, Colin S., et al.
Publicado: (2019) -
Comparing efficacy of reduced-fluence and standard-fluence photodynamic therapy in the treatment of polypoidal choroidal vasculopathy
por: Ngo, Wei Kiong, et al.
Publicado: (2020) -
Treatment of polypoidal choroidal vasculopathy with intravitreal bevacizumab monotherapy
por: Tan, Colin S H, et al.
Publicado: (2013) -
Comparison of Ranibizumab With or Without Verteporfin Photodynamic Therapy for Polypoidal Choroidal Vasculopathy: The EVEREST II Randomized Clinical Trial
por: Lim, Tock H., et al.
Publicado: (2020)